Bovine lactoferrin protects lipopolysaccharide-induced diarrhea modulating nitric oxide and prostaglandin E2 in mice

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 2, 2007, Pages 200-208

  Talukder, M Jamilur R ^a,c   Harada, Etsumori ^b  

^a BANGLADESH AGRICULTURAL UNIVERSITY   (Bangladesh)

^b TOTTORI UNIVERSITY   (Japan)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bovine lactoferrin; Diarrhea; Lipopolysaccharide; Mice; Nitric oxide; Prostaglandin E2

Indexed keywords

INDOMETACIN; LACTOFERRICIN; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; GASTROINTESTINAL TRANSIT; INTESTINE CELL; INTESTINE FLUID; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE;

ANIMALS; CATTLE; DIARRHEA; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL CONTENTS; GASTROINTESTINAL TRANSIT; LACTOFERRIN; LIPOPOLYSACCHARIDES; MALE; MICE; NITRIC OXIDE;

EID: 34249787889     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-004     Document Type: Article

References (35)

1. Actor, J.K., Hwang, S.A., Olsen, M., Zimecki, M., Hunter, R.L., and Kruzel, M.L. 2002. Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacol. 2: 475-486. doi: 10.1016/S1567-5769(01)00189-8.
2. Adamik, B., and Wlaszczyk, A. 1996. Lactoferrin: its role in defense against infection and immunotropic properties. Postepy Hig. Med. Dosw. 50: 33-41.
3. Brock, J. 1995. Lactoferrin: a multifunctional immunoregulatory protein. Immunol. Today, 16: 417-419. doi:10.1016/0167-5699(95)80016-6.
4. Cullen, J.J., Mercer, D., Hinkhouse, M., Ephgrave, K.S., and Conklin, J.L. 1999. Effects of endotoxin on regulation of intestinal smooth muscle nitric oxide synthase and intestinal transit. Surgery, 125: 339-344.
5. Edde, L., Hipolito, R.B., Hwang, F.F., Headon, D.R., Shalwitz, R.A., and Sherman, M.P. 2001. Lactoferrin protects neonatal rats from gut-related systemic infection. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1140-G1150.
6. Eskandari, M.K., Kalff, J.C., Billiar, T.R., Lee, K.K., and Bauer, A.J. 1997. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am. J. Physiol. 273: G727-G734.
7. Eskandari, M.K., Kalff, J.C., Billiar, T.R., Lee, K.K., and Bauer, A.J. 1999. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am. J. Physiol. 277: G478-G486.
8. Harada, E., Itoh, Y., Sitizyo, K., Takeuchi, T., Araki, Y., and Kitagawa, H. 1999. Characteristic transport of lactoferrin from the intestinal lumen into bile via the blood in piglets. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 124: 321-327.
9. Hewett, J.A., and Roth, R.A. 1993. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45: 382-411.
10. Hori, M., Kita, M., Torihashi, S., Miyamoto, S., Won, K.J., Sato, K., Ozaki, H., and Karaki, H. 2001. Up regulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G930-G938.
11. Kruzel, M.L., Harari, Y., Chen, C.Y., and Castro, G.B. 1998. The gut: A key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice. In Advances in lactoferrin research. Edited by G. Spik, D. Legrand, J. Mazurier, A. Pierce, and J.P. Perraudin. Plenum Press, New York and London, pp. 167-173.
12. Kruzel, M.L., Harari, Y., Mailman, D., Actor, J.K., and Zimecki, M. 2002. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin. Exp. Immunol. 130: 25-31. doi: 10.1046/j.1365-2249.2002.01956.x.
13. Lefebvre, R.A. 1997. Influence of endotoxin on contractility in the rat gastric fundus. Eur. J. Pharmacol. 339: 201-209. doi: 10.1016/S0014-2999(97)01385-X.
14. 2. World J. Gastroenterol. 11: 357-361.
15. Machnicki, M., Zimecki, M., and Zagulski, T. 1993. Lactoferrin regulates the release of tumor necrosis factor-alpha and interleukin-6 in vivo. Int. J. Exp. Pathol. 74: 433-439.
16. Mailman, D., Guntuku, S., Bhuiyan, M.B., and Murad, F. 2001. Organ sites of lipopolysaccharide-induced nitric oxide production in the anesthetized rat. Nitric Oxide, 5: 243-251. doi:10.1006/niox.2001.0352.
17. Masson, P.L., Heremans, J.F., and Dive, C. 1966. An iron-binding protein common to many external secretion. Clin. Chim. Acta, 14: 735-739. doi:10.1016/0009-8981(66)90004-0.
18. Mattsby-Baltzer, I., Roseanu, A., Motas, C., Elveerfors, J., Engberg, I., and Hanson, L.A. 1996. Lactoferrin or a fragment thereof inhibits the endotoxin induced interleukin-6 response in human monocytic cells. Pediatr. Res. 40: 257-262.
19. Mishima, S., Xu, D., Lu, Q., and Deitch, E.A. 1998. The relationships among nitric oxide production, bacterial translocation, and intestinal injury after endotoxin challenge in vivo. J. Trauma, 44: 175-182.
20. Mujumdar, A.M., Upadhaye, A.S., and Misar, A.V. 2000. Studies on antidiarrheal activity of Jatropha curcus root extract in albino mice. J. Ethnopharmacol. 70: 183-187. doi:10.1016/S0378-8741(99)00167-1.
21. Nathan, C.F. 1987. Secretory products of macrophages. J. Clin. Invest. 79: 319-326.
22. Ochoa, T.J., Noguera-Obenza, M., Ebel, F., Guzman, C.A., Gomez, H.F., and Geary, T.G. 2003. Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect. Immun. 71: 5149-5155. doi:10.1128/IAI.71.9.5149-5155.2003.
23. Otsuki, K., Yoda, K., Toma, Y., Shimizu, Y., Saito, H., and Yanaihara, T. 1998. Lactoferrin and interleukin-6 interaction in amniotic infection. In Advances in lactoferrin research. Edited by G. Spik, D. Legrand, J. Mazurier, A. Pierce, and J.P. Perraudin. Plenum Press, New York and London, pp. 267-271.
24. Puig, M.M., Warner, W., and Pol, O. 2000. Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice. Anesthesiology, 93: 219-230. doi: 10.1097/00000542-200007000-00033.
25. Schroeder, R.A., delaTorre, A., and Kuo, P.C. 1997. CD14-dependent mechanism for endotoxin-mediated nitric oxide synthesis in murine macrophages. Am. J. Physiol. 273: C1030-C1039.
26. Shimazaki, K., Tsuda, H., Tomita, M., Kuwata, T., and Perraudin, J.P. 2000. Lactoferrin: structure, function and application. Elsevier, Amsterdam.
27. Talukder, M.J.R., and Harada, E. 2006. Binding characteristics and distribution of lactoferrin receptors in the gut and choroid plexus in newborn calves. Indian J. Exp. Biol. 44: 783-790.
28. Talukder, M.J.R., Takeuchi, T., and Harada, E. 2002. Transport of colostral macromolecules into the cerebrospinal fluid via plasma in newborn calves. J. Dairy Sci. 85: 514-524.
29. Talukder, M.J.R., Takeuchi, T., and Harada, E. 2003a. Receptor mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves. J. Vet. Med. Sci. 65: 957-964. doi: 10.1292/jvms.65.957.
30. Talukder, M.J.R., Takeuchi, T., and Harada, E. 2003b. Characteristics of lactoferrin receptor in bovine intestine: higher binding activity to the epithelium overlying Peyer's patches. J. Vet. Med. A Physiol. Pathol. Clin. Med. 50: 123-131.
31. Theodorou, V., Chovet, M., Eutamene, H., Fargeau, H., Dassaud, M., Toulouse, M., et al. 2002. Antidiarrheal properties of a novel sigma ligand (JO 2871) on toxigenic diarrhea in mice: Mechanisms of action. Gut, 51: 522-528. doi:10.1136/gut.51.4.522.
32. Tunctan, B., Uludag, O., Altug, S., and Abacioglu, N. 1998. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol. Res. 38: 405-411. doi:10.1006/phrs.1998.0381.
33. Wapnir, R.A., and Teichberg, S. 2002. Regulation mechanisms of intestinal secretion: implications in nutrient absorption. J. Nutr. Biochem. 13: 190-199.
34. Wirthlin, D.J., Cullen, J.J., Spates, S.T., Conklin, J.L., Murray, J., Caropreso, D.K., and Ephgrave, K.S. 1996. Gastrointestinal transit during endotoxemia: the role of nitric oxide. J. Surg. Res. 60: 307-311. doi: 10.1006/jsre.1996.0048.
35. Yamauchi, K., Wakabayashi, H., Hashimoto, S., Teraguchi, S., Hayasawa, H., and Tomita, M. 1998. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. In Advances in lactoferrin research. Edited by G. Spik, D. Legrand, J. Mazurier, A. Pierce, and J.P. Perraudin. Plenum Press, New York and London, pp. 261-266.